课题基金 / 基金详情

Novel implications of THOR hypermethylation in telomere maintenance and gliomageneis.

Novel implications of THOR hypermethylation in telomere maintenance and gliomageneis.
THOR 超甲基化在端粒维持和神经胶质细胞生成中的新意义。
批准号：
304515
负责人：
Tabori Uri
金额：
$66.4万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2019-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=304515&lang=en
关键词：
Biomarker Clinical Trial Glioma Next Generation Sequencing Preclinical Models Promoter Methylation Pyrosequencing Sequenom

项目摘要

项目成果

Tabori Uri的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Gliomas are deadliest brain tumors in children and adults. Relapse is the most common cause of death from gliomas. Tumors ability to recur depends heavily on their ability of cancer cells to grow endlessly or self renew. We have discovered that telomeras
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Uncovering the mechanism and impact of novel genetic and epigenetic promoter alterations on tissue-specific mismatch repair deficient cancers
Dissecting the origins and microenvironment of replication repair deficient hypermutant gliomas for novel immune based therapies
Biological and translational implications of replication repair deficiency and hypermutation in human cancer
Translating genomic discoveries to cure ultrahypermutant mismatch repair deficient brain tumors
海外基金